Boston Scientific Corporation balance sheet
At the end of its fiscal year on Dec 31, 2025, Boston Scientific Corporation reported total assets of $43.67B and shareholders' equity of $24.23B. That works out to a current ratio of 1.62 (current assets ÷ current liabilities).
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $18.10B | $19.04B | $21.00B | $30.57B | $30.78B | $32.23B | $32.47B | $35.14B | $39.40B | $43.67B |
| Current assets | $3.24B | $3.82B | $4.00B | $4.70B | $6.69B | $6.32B | $5.76B | $6.51B | $6.92B | $8.79B |
| Cash & equivalents | $196.00M | $188.00M | $146.00M | $217.00M | $1.73B | $1.93B | $928.00M | $865.00M | $414.00M | $1.97B |
| Current liabilities | $3.59B | $5.65B | $5.26B | $4.87B | $3.68B | $4.27B | $3.80B | $4.93B | $6.40B | $5.44B |
| Long-term debt | $5.42B | $3.81B | — | — | — | — | — | — | — | — |
| Shareholders' equity | $6.73B | $7.01B | $8.73B | $13.88B | $15.33B | $16.62B | $17.57B | $19.28B | $21.77B | $24.23B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 885725 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.